Table 3 Mean gene expression levels of differentially expressed genes between healthy controls and severe COVID-19 survivors
From: Accelerated immune ageing is associated with COVID-19 disease severity
Gene | Healthy Controls | COVID-19 survivors | p value |
|---|---|---|---|
BCL2 | 278.99 | 67.28 | 0.03 |
BCL2L1 | 276.93 | 271.94 | 0.03 |
BID | 29.28 | 54.7 | 0.03 |
BIRC5 | 21.03 | 24.69 | 0.03 |
BAX | 361.4 | 428.67 | 0.02 |
BCL10 | 637.5 | 642.26 | 0.03 |
ATG10 | 39.56 | 25.06 | 0.02 |
ATG12 | 25.81 | 21.35 | 0.02 |
ATG16L1 | 194.77 | 178.78 | 0.02 |
ATG5 | 206.18 | 219.66 | 0.02 |
ATG7 | 211.81 | 75.37 | 0.02 |
BTK | 289.14 | 169.69 | 0.04 |
BST1 | 578.34 | 395.11 | 0.03 |
BST2 | 208.86 | 144.52 | 0.03 |
BLK | 26.86 | 20 | 0.03 |
BLNK | 46.15 | 22.66 | 0.03 |
ATM | 29.97 | 20 | 0.02 |
BMI1 | 123.69 | 134.08 | 0.03 |
CARD11 | 398.91 | 269.75 | 0.05 |
CARD9 | 107.22 | 39.17 | 0.05 |
ABCB1 | 158.99 | 133.05 | 0.001 |
ABL1 | 108.46 | 108.43 | 0.001 |
ADA | 251.94 | 289.47 | 0.001 |
NFKBIA | 3981.45 | 8074.45 | 0.05 |
TNFAIP3 | 1438.51 | 3295.49 | 0.05 |
CCL5 | 776.86 | 1562.88 | 0.05 |
S100B | 20 | 71.49 | 0.04 |
DUSP6 | 1108.61 | 1723.26 | 0.04 |
CCR7 | 199.46 | 28.56 | 0.05 |
CD28 | 109.88 | 58.2 | 0.05 |
BTLA | 189.81 | 47.55 | 0.04 |
LAG3 | 54.16 | 92.48 | 0.05 |
CDKN1A | 305.75 | 514.31 | 0.04 |
GZMB | 1595.35 | 2154.99 | 0.03 |
GZMH | 393.31 | 701.41 | 0.03 |
RORA | 497.25 | 645.93 | 0.05 |
BCL6 | 188.63 | 275.4 | 0.03 |